Press Releases
-
DaVita Honors 25 Years of Clinical Advancement in Chronic Disease CareAs part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensive kidney care, is proud to spotlight the groundbreaking work of its wholly owned research arm, DaVita...
-
DaVita Inc. 2nd Quarter 2025 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2025. "We're reporting another solid quarter, fueled by our unwavering focus on patient care," said...
-
DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 5, 2025, at 5:00 p.m. Eastern Time. The company plans...
-
DaVita Statement on Government’s Kidney Care Choices (KCC) Model Updates
DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care...
-
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering
DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes due 2033 (the "2033 notes"). The...